Avigen ends gene therapy research after 12 years of little success

Email this article to a friend

Printable Version

After 12 years of research into gene therapy, Avigen has decided to end its gene therapy research and stick to traditional pharmaceuticals. Though gene therapy held a great deal of promise for curing numerous ailments, Avigen was never able to produce any proven treatments. However, they will continue clinical trials on their gene therapy for Parkinson's disease.

Avigen is expected to lay off more of its 60-person workforce, but the company may simply fold its gene therapy arm into other projects. However, this shift away from gene therapy should interest investors, as the new focus on standard drugs will cut the company's expenses considerably.

Share

About the author: Mike Adams is a consumer health advocate with a passion for teaching people how to improve their health He has authored more than 1,500 articles and dozens of reports, guides and interviews on natural health topics, reaching millions of readers with information that is saving lives and improving personal health around the world. Adams is an independent journalist with strong ethics who does not get paid to write articles about any product or company. In 2007, Adams launched EcoLEDs, a manufacturer of mercury-free, energy-efficient LED lighting products that save electricity and help prevent global warming. He's also the founder and CEO of a well known email mail merge software developer whose software, 'Email Marketing Director,' currently runs the NaturalNews email subscriptions. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and enjoys outdoor activities, nature photography, Pilates and adult gymnastics. Known by his callsign, the 'Health Ranger,' Adams posts his missions statements, health statistics and health photos at www.HealthRanger.org


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Gene therapy and genetic engineering: the future of medicine? • FDA ready to loosen rules for clinical trials, allowing drug companies to make them up as they go along • Swine flu vaccine shots eliminate wrinkles, bad breath and varicose veins, too (opinion)	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/006809_gene_therapy_clinical_trials_disease.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/006809_gene_therapy_clinical_trials_disease.html">Avigen ends gene therapy research after 12 years of little success</a>